Alicia Elbert

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Assessment of salivary urea as a less invasive alternative to serum determinations

Estela Cardoso, Alejandro L. Arregger, Omar R. Tumilasci et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 2008 · 59 citations

Dentistry, Nephrology, Hemodialysis +14

HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.

Silvia Sanguinetti, F D Brites, V Fasulo et al. · PubMed · 2001 · 41 citations

Life Sciences, Biochemistry, Clinical Biochemistry +16